Albiotic (330 mg + 100 mg)/10 ml Roztwór dowymieniowy
Albiotic (330 mg + 100 mg)/10 ml Roztwór dowymieniowy
Authorised
- Lincomycin
- Neomycin
Product identification
Medicine name:
Albiotic (330 mg + 100 mg)/10 ml Roztwór dowymieniowy
Active substance:
- Lincomycin
- Neomycin
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Lincomycin330.00/milligram(s)1.00Syringe
-
Neomycin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary solution
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal3day
-
Milk72hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RF03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Package description:
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1233
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022